TY - JOUR
T1 - Anti-cancer effects of 3, 3'-diindolylmethane on human hepatocellular carcinoma cells is enhanced by calcium ionophore
T2 - The role of cytosolic Ca2+ and P38 mapk
AU - Jiang, Yuanyue
AU - Fang, Yanfei
AU - Ye, Yang
AU - Xu, Xinming
AU - Wang, Bingfang
AU - Gu, Jie
AU - Aschner, Michael
AU - Chen, Jian
AU - Lu, Rongzhu
N1 - Funding Information:
The present study was financially supported by the Natural Science Foundation of China (No. 81502800, 31271272 and 31600952), China Postdoctoral Science Foundation Funded Project (No. 2015M571694), Jiangsu Planned Projects for Postdoctoral Research Funds (No. 1402169C) and the Research Foundation for Advanced Talents of Jiangsu University (No.14JDG044). We thank Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript. MA was supported by NIH grants NIEHS R01 10563, R01ES07331, and NIEHS R01ES020852.
Funding Information:
Te present study was fnancially supported by the Natural Science Foundation of China (No. 81502800, 31271272 and 31600952), China Postdoctoral Science Foundation Funded Project (No. 2015M571694), Jiangsu Planned Projects for Postdoctoral Research Funds (No. 1402169C) and the Research Foundation for Advanced Talents of Jiangsu University (No.14JDG044). We thank Edanz Group (www.edanzediting.com/ac) for editing a draf of this manuscript. MA was supported by NIH grants NIEHS R01 10563, R01ES07331, and NIEHS R01ES020852.*%blankline%*
Publisher Copyright:
© 2019 Oxford University Press. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Purpose: 3,3'-Diindolylmethane (DIM), derived from indole-3-carbinol (I3C) in the Brassica species of cruciferous vegetables, has anticancer effects, but its exact underlying mechanism of action is unknown. We explored the roles of cytosolic free calcium ([Ca2+]i) and p38 MAPK in the anti-cancer effects of DIM in human hepatocellular carcinoma cells. Methods: Cell proliferation was measured with a Cell Counting Kit-8 (CCK-8) and the clonogenic formation assay. Cell apoptosis was examined by?ow cytometric analysis and Hoechst dye staining. Cleaved-caspase3, cleaved-PARP, Bax, total, and phosphorylated p38 MAPK were assayed by western blotting. [Ca2+]i was measured with Fluo-3/AM by?uorescence microscopy. A23187, a calcium ionophore, was used to increase [Ca2+]i levels. Results: DIM inhibited cell proliferation in both SMMC-7721 and HepG2 cells in a concentration-and time-dependent manner. DIM also enhanced phosphorylation of p38 MAPK (p-p38), which was attenuated by SB203580. The proliferation inhibition and apoptosis induction by DIM were also blunted. In addition, DIM increased [Ca2+]i in HCC cells, and this effect was inhibited by the calcium chelator, BAPTA-AM, resulting in reduced p-p38 MAPK activation and apoptosis in DIM-treated cells, though the proliferation inhibition by DIM was unchanged. However, the DIM-induced cell proliferation inhibition and apoptosis were signifcantly enhanced by A23187, a selective calcium ionophore, which was attributed to exaggerated p-p38 MAPK. Conclusions: The calcium ionophore enhanced DIM-induced anti-cancer effects in hepatocellular carcinoma cells, secondary to [Ca2+]i-dependent activation of p38 MAPK. Treatment with a combination of DIM and calcium ionophore may offer a new approach to enhance the chemotherapeutic effcacy in liver cancer.
AB - Purpose: 3,3'-Diindolylmethane (DIM), derived from indole-3-carbinol (I3C) in the Brassica species of cruciferous vegetables, has anticancer effects, but its exact underlying mechanism of action is unknown. We explored the roles of cytosolic free calcium ([Ca2+]i) and p38 MAPK in the anti-cancer effects of DIM in human hepatocellular carcinoma cells. Methods: Cell proliferation was measured with a Cell Counting Kit-8 (CCK-8) and the clonogenic formation assay. Cell apoptosis was examined by?ow cytometric analysis and Hoechst dye staining. Cleaved-caspase3, cleaved-PARP, Bax, total, and phosphorylated p38 MAPK were assayed by western blotting. [Ca2+]i was measured with Fluo-3/AM by?uorescence microscopy. A23187, a calcium ionophore, was used to increase [Ca2+]i levels. Results: DIM inhibited cell proliferation in both SMMC-7721 and HepG2 cells in a concentration-and time-dependent manner. DIM also enhanced phosphorylation of p38 MAPK (p-p38), which was attenuated by SB203580. The proliferation inhibition and apoptosis induction by DIM were also blunted. In addition, DIM increased [Ca2+]i in HCC cells, and this effect was inhibited by the calcium chelator, BAPTA-AM, resulting in reduced p-p38 MAPK activation and apoptosis in DIM-treated cells, though the proliferation inhibition by DIM was unchanged. However, the DIM-induced cell proliferation inhibition and apoptosis were signifcantly enhanced by A23187, a selective calcium ionophore, which was attributed to exaggerated p-p38 MAPK. Conclusions: The calcium ionophore enhanced DIM-induced anti-cancer effects in hepatocellular carcinoma cells, secondary to [Ca2+]i-dependent activation of p38 MAPK. Treatment with a combination of DIM and calcium ionophore may offer a new approach to enhance the chemotherapeutic effcacy in liver cancer.
KW - 3,3'-diindolylmethane
KW - Apoptosis
KW - Cytosolic Ca
KW - Hepatocellular carcinoma cells
KW - P38 MAPK
KW - Proliferation
UR - http://www.scopus.com/inward/record.url?scp=85074208554&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074208554&partnerID=8YFLogxK
U2 - 10.3389/fphar.2019.01167
DO - 10.3389/fphar.2019.01167
M3 - Article
AN - SCOPUS:85074208554
SN - 1663-9812
VL - 10
JO - Frontiers in Pharmacology
JF - Frontiers in Pharmacology
M1 - 1167
ER -